跳转至内容
Merck
CN

S1764

Sigma-Aldrich

补体血清 人

lyophilized powder

别名:

Human Serum Complement

登录查看公司和协议定价


About This Item

MDL编号:
UNSPSC代码:
12352202
NACRES:
NA.61
生物来源:
human
来源:
USA origin
表单:
lyophilized powder
运输:
dry ice

生物来源

human

质量水平

表单

lyophilized powder

来源

USA origin

技术

cell culture | mammalian: suitable

杂质

virus, tested

运输

dry ice

储存温度

−20°C

相关类别

一般描述

补体血清从混合的人血浆中制备,并根据标签上指示的血清量进行冻干。

应用

人补体血清已用于:
  • 培养DLD-1或SW-620细胞,以量化C5a释放
  • 多重头抗体C3d结合试验
  • 补体依赖性细胞毒性试验

人补体血清已用于:
  • 培养DLD-1或SW-620细胞,以量化C5a释放
  • 多重头抗体C3d结合试验
  • 补体依赖性细胞毒性试验

补体血清的活性可通过体外溶血试验测定。

外形

由标签所示含量血清制成的冻干粉末

分析说明

溶血滴度(CH50单位/ml)通过Kabat/Mayer法测定。实际滴度见标签。

免责声明

仅供研究使用。本品在法国的科研应用受到监管,包括用于进口和出口活动(法国《公共卫生法典》Public Health Code Article L 1211-1 paragraph 2)。如《公共卫生法典》所述,购买者(即最终用户)需要从法国研究部(France Ministry of Research)获得进口授权。订购此产品即代表您已确认获得合法的进口授权。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

高风险级别生物产品--人源产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

David A Spencer et al.
Nature communications, 13(1), 662-662 (2022-02-05)
Increasingly, antibodies are being used to treat and prevent viral infections. In the context of HIV, efficacy is primarily attributed to dose-dependent neutralization potency and to a lesser extent Fc-mediated effector functions. It remains unclear whether augmenting effector functions of
Savannah E Butler et al.
medRxiv : the preprint server for health sciences (2020-08-15)
Understanding humoral immune responses to SARS-CoV-2 infection will play a critical role in the development of vaccines and antibody-based interventions. We report systemic and mucosal antibody responses in convalescent individuals who experienced varying disease severity. Robust antibody responses to diverse
Savannah E Butler et al.
Frontiers in immunology, 11, 618685-618685 (2021-02-16)
Understanding humoral immune responses to SARS-CoV-2 infection will play a critical role in the development of vaccines and antibody-based interventions. We report systemic and mucosal antibody responses in convalescent individuals who experienced varying severity of disease. Whereas assessment of neutralization
Yui Suzuki et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 25(14), 4388-4399 (2019-04-26)
The anti-CCR4 mAb, mogamulizumab, offers therapeutic benefit to patients with adult T-cell leukemia-lymphoma (ATL), but skin-related adverse events (AE) such as erythema multiforme occur frequently. The purpose of this study was to determine the mechanisms by which mogamulizumab causes skin-related
Chiaki Kawabata et al.
Biological & pharmaceutical bulletin, 44(2), 219-224 (2021-02-02)
Baculovirus vectors (BVs) are safely able to transduce foreign genes and express them in mammalian cells. However, the transduction activity of BVs is strongly reduced by the attack of serum complement, which is one of the major obstacles in the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门